From the Division of Neurosurgery, St Michael's Hospital, Labatt Family Centre of Excellence in Brain Injury and Trauma Research, Keenan Research Centre of the Li Ka Shing Knowledge Institute of St Michael's Hospital and Department of Surgery, University of Toronto, Toronto, Ontario, Canada (B.N.J., T.R.M., D.T.P., T.A.S., R.L.M.); Neuroscience Research Program, Keenan Research Centre of the Li Ka Shing Knowledge Institute of St. Michael's Hospital (A.L.d.O.M, H.Y., W.Q., E.K.); and Department of Neurosurgery, St Elisabeth Ziekenhuis, Tilburg, Netherlands (M.R.G.).
Stroke. 2015 Jul;46(7):1826-31. doi: 10.1161/STROKEAHA.115.008728. Epub 2015 May 14.
Patients are classically at risk of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage. We validated a grading scale-the VASOGRADE-for prediction of DCI.
We used data of 3 phase II randomized clinical trials and a single hospital series to assess the relationship between the VASOGRADE and DCI. The VASOGRADE derived from previously published risk charts and consists of 3 categories: VASOGRADE-Green (modified Fisher scale 1 or 2 and World Federation of Neurosurgical Societies scale [WFNS] 1 or 2); VASOGRADE-Yellow (modified Fisher 3 or 4 and WFNS 1-3); and VASOGRADE-Red (WFNS 4 or 5, irrespective of modified Fisher grade). The relation between the VASOGRADE and DCI was assessed by logistic regression models. The predictive accuracy of the VASOGRADE was assessed by receiver operating characteristics curve and calibration plots.
In a cohort of 746 patients, the VASOGRADE significantly predicted DCI (P<0.001). The VASOGRADE-Yellow had a tendency for increased risk for DCI (odds ratio [OR], 1.31; 95% CI, 0.77-2.23) when compared with VASOGRADE-Green; those with VASOGRADE-Red had a 3-fold higher risk of DCI (OR, 3.19; 95% CI, 2.07-4.50). Studies were not a significant confounding factor between the VASOGRADE and DCI. The VASOGRADE had an adequate discrimination for prediction of DCI (area under the receiver operating characteristics curve=0.63) and good calibration.
The VASOGRADE results validated previously published risk charts in a large and diverse sample of subarachnoid hemorrhage patients, which allows DCI risk stratification on presentation after subarachnoid hemorrhage. It could help to select patients at high risk of DCI, as well as standardize treatment protocols and research studies.
患者在颅内动脉瘤性蛛网膜下腔出血后通常有发生迟发性脑缺血(DCI)的风险。我们验证了一种用于预测 DCI 的分级量表-VASOGRADE。
我们使用了 3 项 II 期随机临床试验和 1 项单中心系列研究的数据来评估 VASOGRADE 与 DCI 之间的关系。VASOGRADE 源自先前发表的风险图表,由 3 个类别组成:VASOGRADE-Green(改良 Fisher 量表 1 或 2 级和世界神经外科学会联合会量表[WFNS]1 或 2 级);VASOGRADE-Yellow(改良 Fisher 量表 3 或 4 级和 WFNS 1-3 级);和 VASOGRADE-Red(WFNS 4 或 5 级,不论改良 Fisher 分级如何)。通过逻辑回归模型评估 VASOGRADE 与 DCI 之间的关系。通过接收者操作特征曲线和校准图评估 VASOGRADE 的预测准确性。
在 746 例患者的队列中,VASOGRADE 显著预测了 DCI(P<0.001)。与 VASOGRADE-Green 相比,VASOGRADE-Yellow 有增加 DCI 风险的趋势(优势比[OR],1.31;95%CI,0.77-2.23);VASOGRADE-Red 的 DCI 风险增加了 3 倍(OR,3.19;95%CI,2.07-4.50)。研究不是 VASOGRADE 与 DCI 之间的显著混杂因素。VASOGRADE 对 DCI 的预测具有适当的区分度(接收者操作特征曲线下面积=0.63)和良好的校准度。
VASOGRADE 在大量和多样化的蛛网膜下腔出血患者样本中验证了先前发表的风险图表,这使得在蛛网膜下腔出血后可以对 DCI 风险进行分层。它可以帮助选择 DCI 风险较高的患者,并标准化治疗方案和研究。